GILLIAN C IVERS-READ Insider Trading $CLVS Clovis Oncology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GILLIAN C IVERS-READ.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GILLIAN C IVERS-READ. GILLIAN C IVERS-READ is Vice President in PHARMION CORP ($PHRM) and VP, Clin. Dev. & Reg. Affairs in PHARMION CORP ($PHRM) and VP-Clinical Dev.& Reg. Affairs in PHARMION CORP ($PHRM) and Director in BIO-PATH HOLDINGS INC ($BPTH) and See Remarks in Clovis Oncology, Inc. ($CLVS).
GILLIAN C IVERS-READ in Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GILLIAN C IVERS-READ: See Remarks
Holdings: 248,828 shares
Current Value: $14,929,680
Latest Transaction: May 04 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GILLIAN C IVERS-READ in Clovis Oncology, Inc.
Sentiment: All, BPTH, CLVS, PHRM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 54.09 | 3,000 | 162,270 | 180,571 | 183.6 K to 180.6 K (-1.63 %) |
| Jan 17 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 59.16 | 3,000 | 177,480 | 183,571 | 186.6 K to 183.6 K (-1.61 %) |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 63.80 | 3,512 | 224,066 | 186,571 | 190.1 K to 186.6 K (-1.85 %) |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 7,500 | 0 | 190,083 | 182.6 K to 190.1 K (+4.11 %) |
| Dec 18 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 64.16 | 3,000 | 192,480 | 182,583 | 185.6 K to 182.6 K (-1.62 %) |
| Nov 16 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 63.70 | 3,000 | 191,100 | 185,583 | 188.6 K to 185.6 K (-1.59 %) |
| Oct 17 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 84.54 | 3,000 | 253,620 | 188,583 | 191.6 K to 188.6 K (-1.57 %) |
| Sep 18 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 69.50 | 3,000 | 208,500 | 191,583 | 194.6 K to 191.6 K (-1.54 %) |
| Aug 15 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 70.05 | 3,000 | 210,150 | 194,583 | 197.6 K to 194.6 K (-1.52 %) |
| Jul 17 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 91.56 | 3,000 | 274,680 | 197,583 | 200.6 K to 197.6 K (-1.50 %) |
| Jun 15 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 61.82 | 3,000 | 185,460 | 200,583 | 203.6 K to 200.6 K (-1.47 %) |
| May 15 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 47.39 | 3,000 | 142,170 | 203,583 | 206.6 K to 203.6 K (-1.45 %) |
| Apr 17 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 56.02 | 3,000 | 168,060 | 206,583 | 209.6 K to 206.6 K (-1.43 %) |
| Mar 28 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Mar 28 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 68.31 | 20,000 | 1,366,200 | 20,000 | |
| Mar 15 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 66.99 | 3,000 | 200,970 | 209,583 | 212.6 K to 209.6 K (-1.41 %) |
| Dec 19 2016 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Sep 19 2016 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | J | 79.05 | 8,750 | 691,688 | 26,250 | |
| Oct 16 2015 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 91.91 | 3,000 | 275,730 | 212,583 | 215.6 K to 212.6 K (-1.39 %) |
| Sep 22 2015 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 112.56 | 3,000 | 337,680 | 215,583 | 218.6 K to 215.6 K (-1.37 %) |
| Mar 04 2015 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 79.05 | 35,000 | 2,766,750 | 35,000 |